We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
